After tense negotiations, Gilead Sciences has agreed not to boost prices next year for HIV medicines that are sold to state ...

Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Also! In honor of World CRISPR Day (yesterday, but close enough), we have a very special 50% discount rate if you sign up for ...

Announcements from Abridge and OpenEvidence at HLTH highlight how the once distinct artificial intelligence startups are now ...

FDA drug approvals dropped in the third quarter, more marketing applications were rejected than in previous months, and more ...

Despite the mechanisms that made it a “biologically plausible” candidate, the study found that participants who took the drug didn’t have better functional capacity or respiratory function than those ...

Trust in public health institutions has been declining for years. Popular YouTuber “Doctor Mike” has some ideas for how to ...

Competitive bidding for catheters means reduced patient choice, jeopardized supply chains, and an incentive to push cheap, ...

The American Medical Association announced a new Center for Digital Health and AI. In a Q&A, AMA CEO John Whyte discusses its ...

One of the greatest lessons of the last five years is that public health needs to step up its game in dealing with ...

CDC researchers are being forced to skip a pivotal conference on infectious disease this week due to the government shutdown, ...